Key takeaways
- The grade is set by study design: cell, animal, small human report, controlled human trial, and, on a separate axis, regulatory approval.
- Grades attach to one compound, one use and one route. Topical GHK-Cu and injected GHK-Cu are graded separately.
- A controlled trial earns its grade even when its result is negative or mixed. The grade says how well a question was tested, not what the answer was.
- Animal results are a reason to study something in people, not evidence that it works in people: a systematic review found treatments that helped in animal models and then showed no benefit, or worse outcomes, in patients.
- Grades change when new studies publish, when we correct a classification, and when we re-read a page against current evidence.
01The scale
The scale runs Cell → Animal → Human pilot → Controlled trials, with regulatory approval on its own line. Some guides show it as a research bar; others give the internal tier from the table below (T4 to T1). Each area of research gets the highest step it has reached; a guide’s headline shows the area most of its research addresses.
| Step | What counts | Grade shown | Internal tier | Example from our register |
|---|---|---|---|---|
| Cell | Cells or tissue studied outside a living body (in vitro, explants), including cells taken from animals | Preclinical | T4 | BPC-157 on rat tendon explants and cultured tendon cells (Chang et al., 2011) |
| Animal | Studies in live animals | Preclinical | T3 | BPC-157 after Achilles tendon transection in rats (Staresinic et al., 2003); KPV in mouse colitis models (Dalmasso et al., 2008) |
| Human pilot | Small human studies without a proper comparison group, case series, case reports, early pharmacology studies | Very limited / early human | T2 | BPC-157: three small uncontrolled pilot studies (McGuire et al., 2025); ipamorelin: a pharmacology study in 40 healthy men (Gobburu et al., 1999) |
| Controlled trials | Randomised human trials with a placebo or comparison group | Controlled human trials | T1 | CJC-1295, in the long-acting form tested in 2006: two placebo-controlled studies that measured GH and IGF-1 (Teichman et al., 2006); thymosin β4 eye drops, phase 2, n=72 (Sosne and Ousler, 2015) |
| Regulatory approval | A regulator approved a specific product for a specific use | Approved (that use only) | fact | Semaglutide and tirzepatide, prescription medicines approved after large phase 3 trials |
| Not graded | Anecdotes, forums, influencer claims, vendor pages | Never used | T0 | — |
How sources are ranked before they reach this scale is set out in source standards. To compare compounds side by side, use the evidence grade explorer in tools.
02Six rules for assigning a grade
Each area studied gets the grade of its strongest source. GHK-Cu has small human studies for topical use and none for injection, so the two are graded apart. Thymosin β4 eye-drop trials used the full 43-amino-acid protein; they do not grade injected TB-500, which usually means a 7-amino-acid fragment. A guide’s headline grade reflects the area most of its research addresses; the evidence map grades every area separately.
Evidence attaches to the compound studied. A blend or a pair gets no grade from its parts. We found, for example, no published or registered human study of CJC-1295 and ipamorelin together (PubMed and ClinicalTrials.gov, November 2026).
A controlled trial earns the controlled-trial grade whatever it found. Thymosin β4 eye drops have controlled trials, and the phase 2 dry-eye trial missed both of its primary endpoints (Sosne and Ousler, 2015). The grade stays; the guide says the results are mixed.
The 2006 CJC-1295 trials measured hormone levels, not muscle, fat or performance. The grade carries that qualifier: controlled trials, biomarkers only.
A study on cells or tissue taken from an animal is a cell study. The animal grade needs a living animal.
Several BPC-157 studies are registered on ClinicalTrials.gov; as of 18 November 2026 none has posted results. Until results are published, they do not change the grade.
03Why animal results don't transfer automatically
Animal studies are how almost every medicine starts. They are also a weak predictor of what happens in people.
- Animal benefit can become human harm. A systematic review (Perel et al., BMJ, 2007) found that the stroke drug tirilazad improved outcomes in animal models, yet was associated with worse outcomes in patients. Corticosteroids helped in animal models of head injury and showed no benefit in clinical trials.
- It cuts both ways. Semaglutide causes thyroid C-cell tumours in rodents; its US label says whether it does so in humans is unknown. Animal findings, good or bad, are questions for human research, not answers.
The reasons are ordinary: different species, disease models that do not mimic the human condition, and small studies prone to bias.
04How grades change
A controlled trial published in full moves a compound up the bar for that use. A press release, a conference talk or a conference abstract does not.
Grades can go down. Chang et al. (2011) was first filed in our register as an animal study of BPC-157; on re-reading, it was tendon explants and cultured cells, so it was re-tiered to cell evidence.
Approvals update the separate approval line, dated to the decision. Advisory votes and enforcement policies do not change a grade or an approval status.
Published pages are re-read against current evidence, and legal-status pages are rechecked on a fixed schedule and after every relevant regulatory event, as set out in our editorial policy and how we check every page.
05What a grade can't tell you
- Whether something works. Controlled trials can be negative. Preclinical findings can be striking and still fail in people.
- How big an effect is, or whether it matters to a person. Read the guide for what was measured.
- Whether something is safe. See are peptides safe and peptide side effects.
- Study quality within a step. Formal systems such as GRADE (Guyatt et al., BMJ, 2008) also rate risk of bias, consistency and precision. Our scale is simpler and based on design; we do not present it as a GRADE rating.
This content is educational. It is not medical advice and does not describe use in humans. 6AM Wellness products are sold for research use only and are not for human consumption. If you have a health condition, consult a licensed clinician who knows you.